Graph prism software 7

Manufactured by GraphPad

Sourced in United States

GraphPad Prism 7.0 is a data analysis and graphing software. It provides tools for data organization, statistical analysis, and creating publication-quality graphs and figures.

Automatically generated - may contain errors

Lab products found in correlation

Spelling variants of this product

GraphPad Prism 7 (32527 citations) Prism software (8870 citations) GraphPad Prism software 7.0 (227 citations) Graph Prism (220 citations) Graph Prism 7.0 (50 citations) Graph Pad Prism 7.0 Statistical Software (2 citations)

4 protocols using graph prism software 7

Cell Viability Assay for Leukemia

Check if the same lab product or an alternative is used in the 5 most similar protocols

Leukemia cells were seeded in 96-well plates at a density of 1 × 10³ cells per well. The cell viability was determined by Cell Counting kit-8 (CCK8) assay (Dojindo Molecular Technologies, Tokyo, Japan) according to the manufacturer’s instructions. Cell proliferation was calculated as a percentage of that in cells in control medium. Each concentration was tested in triplicate and repeated in at least three independent experiments. The calculation was performed by Graph Prism software 7.0 (GraphPad Software Inc., San Diego, CA, USA).

Jiang Y., Wu S.Y., Chen Y.L., Zhang Z.M., Tao Y.F., Xie Y., Liao X.M., Li X.L., Li G., Wu D., Wang H.R., Zuo R., Cao H.B., Pan J.J., Yu J.J., Jia S.Q., Zhang Z., Chu X.R., Zhang Y.P., Feng C.X., Wang J.W., Hu S.Y., Li Z.H., Pan J., Fang F, & Lu J. (2021). CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1. Cancer Cell International, 21, 598.

+ Open protocol

+ Expand

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols

Student’s t-tests were used to compare two groups. Three or more groups were analyzed with one-way analysis of variance. For all tests, p < 0.05 was considered statistically significant. Graphs were generated using GraphPrism software 7.0 (GraphPad Software Inc., San Diego, CA, USA). All data are expressed as mean ± SD.

Wang H., Ding Y., Zhang W., Wei K., Pei Y., Zou C., Zhang C., Ding J., Fang H, & Tan S. (2020). Oxymatrine Liposomes for Intervertebral Disc Treatment: Formulation, in vitro and vivo Assessments. Drug Design, Development and Therapy, 14, 921-931.

+ Open protocol

+ Expand

Optimizing Cell Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols

All date shown were mean ± standard deviation (SD). Statistical analyses were performed using ANOVA followed by Tukey's post hoc analysis (Graph prism software 7.0, USA). A statistically significant difference is considered if p is less than 0.05.

Wei Q., Liu D., Chu G., Yu Q., Liu Z., Li J., Meng Q., Wang W., Han F, & Li B. (2022). TGF-β1-supplemented decellularized annulus fibrosus matrix hydrogels promote annulus fibrosus repair. Bioactive Materials, 19, 581-593.

+ Open protocol

+ Expand

Protein Quantification in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

All experiments were performed independently at least three times. Statistically significant differences were determined using the unpaired t-test. Graphprism software 7.0 was used for statistical analyses. Data are reported as mean ± SEM with significance set at P < 0.05. p-values for each experiment are provided in the figure legends.

Park H.H., Kim H., Lee H.S., Seo E.U., Kim J.E., Lee J.H., Mun Y.H., Yoo S.Y., An J., Yun M.Y., Kang N.W., Kim D.D., Na D.H., Hong K.S., Jang J.G., Ahn J.H., Bae J.S., Song G.Y., Lee J.Y., Kim H.N, & Lee W. (2021). PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials, 273, 120827.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!